Clicky

Author name: systems

Depressive symptoms may hasten kidney function decline in adults without kidney disease

Source/Disclosures Published by: Disclosures: Qin reports being employed by the Renal Division, Nanfang Hospital, Southern Medical University and the National Clinical Research Center for Kidney Disease and receiving grants from the National Natural Science Foundation of China. Please see the study for all other authors’ relevant financial disclosures. […]

Depressive symptoms may hasten kidney function decline in adults without kidney disease Read More »

Study of 1.2 Million People Explores Genetic Risk for Depression

A massive genome-wide association study (GWAS) of genetic and health records of 1.2 million people from four separate data banks has identified 178 gene variants linked to major depression, a disorder that will affect one of every five people during their lifetimes. The results of the study, led by the U.S. Department of Veterans Affairs (V.A.)

Study of 1.2 Million People Explores Genetic Risk for Depression Read More »

How to Get Help When You’re Suffering With Postpartum Depression

©ISTOCKPHOTO.COM/ELENA STANOJKOVIC Being a new mom is challenging enough—balancing feeding, cleaning and caring for your baby on little to no sleep. Now add in hormonal ups and downs, emotional overload, birth plan disappointments, identity issues, irritability and anxiety over everything from whether the baby is breathing properly to how you’ll be able to afford to

How to Get Help When You’re Suffering With Postpartum Depression Read More »

The Pandemic Worsened Young Women’s Depression and Anxiety More than Young Men’s

Newswise — The COVID-19 pandemic has had an uneven impact on mental health, affecting young women more adversely in some regards than young men, a new study suggests. Income loss likewise was associated with increases in depression. At the same time, however, the young people actually showed a reduction in binge drinking and alcohol problems.

The Pandemic Worsened Young Women’s Depression and Anxiety More than Young Men’s Read More »

Psychedelic Company Forges Ahead in Developing New Treatments for Depression

Compass Pathways, the UK-based mental health care company that’s innovating new mental health treatments, recently announced that it had been granted two new patents in the US. These patents cover the use of its oral formulations of synthetic psilocybin, the active ingredient in magic mushrooms, to treat major depressive disorder (MDD) and treatment-resistant depression (TRD).

Psychedelic Company Forges Ahead in Developing New Treatments for Depression Read More »